Citation: Qin Xuan, Zhao Hui, Jiang Yanhong, Yin Feng, Tian Yuan, Xie Mingsheng, Ye Xiyang, Xu Naihan, Li Zigang. Development of a potent peptide inhibitor of estrogen receptor α[J]. Chinese Chemical Letters, ;2018, 29(7): 1160-1162. doi: 10.1016/j.cclet.2018.04.004 shu

Development of a potent peptide inhibitor of estrogen receptor α

Qin Xuan ^a,1 ,
Zhao Hui ^a,1 ,
Jiang Yanhong ^a ,
Yin Feng ^a ,
Tian Yuan ^b ,
Xie Mingsheng ^a ,
Ye Xiyang ^c ,
Xu Naihan ^d ,
Li Zigang ^a,,

a.
School of Chemical Biology and Biotechnology, Shenzhen Graduate School of Peking University, Shenzhen 518055, China
b.
School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 611756, China
c.
Department of Gynecology, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China
d.
Key Lab in Healthy Science and Technology, Division of Life Science, Shenzhen Graduate School of Tsinghua University, Shenzhen 518055, China

Corresponding author: Li Zigang, lizg@pkusz.edu.cn

Received Date: 20 January 2018
Revised Date: 15 March 2018
Accepted Date: 19 March 2018
Available Online: 4 July 2018

Figures(4)

We have developed a facile N-terminus helix-nucleating strategy using an unnaturally tethered aspartic acid (TD strategy). Relatively weak nuclear translocation efficiency of TD PERM limits its further biological applications. A potent peptide inhibitor of estrogen receptor α (ER-α) with significantly increased cellular uptake and cellular distribution was developed by cell penetrating peptide attachment. The resulted peptide conjugate showed selective toxicity towards estrogen receptor positive cell lines and induced decreased transcription of estrogen receptor α downstream genes.
- Peptide inhibitor,
- TD strategy,
- N-terminus helix-nucleating strategy,
- Estrogen receptor α,
- Cell penetrating peptide
1. [1]
  B. Fisher, J.P. Costantino, D.L. Wickerham, et al., J. Natl. Cancer Inst. 97(2005) 1652-1662. doi: 10.1093/jnci/dji372
2. [2]
  (a) T. Nasomyon, S. Samphao, S. Sangkhathat, et al., Anticancer Res. 34 (2014) 1333-1342;
  (b) S. J. Howell, S. R. Johnston, A. Howell, Best Pract. Res. Clin. Endocrinol. Metab. 18 (2004) 47-66;
  (c) A. D'Assoro, R. Busby, I. Acu, et al., Oncogene 27 (2008) 3901-3911;
  (d) R. L. Dillon, R. Marcotte, B. T. Hennessy, et al., Cancer Res. 69 (2009) 5057-5064.
3. [3]
  (a) B. Fisher, J. P. Costantino, D. L. Wickerham, et al., J. Natl. Cancer Inst. 90 (1998) 1371-1388;
  (b) Y. J. Kwon, D. R. Hurst, A. D. Steg, et al., Clin. Exp. Metastasis 28 (2011) 437-449.
4. [4]
  (a) L. Bernstein, D. Deapen, J. R. Cerhan, et al., J. Natl. Cancer Inst. 91 (1999) 1654-1662;
  (b) Y. Shang, M. Brown, Science 295 (2002) 2465-2468.
5. [5]
  A.K. Shiau, D. Barstad, P.M. Loria, et al., Cell 95(1998) 927-937. doi: 10.1016/S0092-8674(00)81717-1
6. [6]
  (a) J. M. Hall, C. Y. Chang, D. P. McDonnell, Mol. Endocrinol. 14 (2000) 2010-2023;
  (b) A. M. Leduc, J. O. Trent, J. L. Wittliff, et al., Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11273-11278;
  (c) A. K. Galande, K. S. Bramlett, J. O. Trent, et al., ChemBioChem 6 (2005) 1991-1998;
  (d) T. Phan, H. D. Nguyen, H. Göksel, et al., Chem. Commun. 46 (2010) 8207-8209;
  (e) C. Phillips, L. R. Roberts, M. Schade, et al., J. Am. Chem. Soc. 133 (2011) 9696-9699.
7. [7]
  (a) M. Carraz, W. Zwart, T. Phan, et al., Chem. Biol. 16 (2009) 702-711;
  (b) K. Tints, M. Prink, T. Neuman, et al., Int. J. Mol. Sci. 15 (2014) 5680-5698.
8. [8]
  J.S. Zheng, M. Yu, Y.K. Qi, et al., J. Am. Chem. Soc. 136(2014) 3695-3704. doi: 10.1021/ja500222u
9. [9]
  (a) H. Zhao, Q. S. Liu, H. Geng, et al., Angew. Chem. Int. Ed. 128 (2016) 12267-12272;
  (b) Y. H. Jiang, Q. W. Deng, H. Zhao, et al., ACS Chem. Biol. 13 (2018) 628-635;
  (c) M. S. Xie, H. Zhao, Q. S. Liu, et al., J. Med. Chem. 60 (2017) 8731-8740.
10. [10]
  D. Delaroche, B. Aussedat, S. Aubry, et al., Anal. Chem. 79(2007) 1932-1938. doi: 10.1021/ac061108l
11. [11]
  N.A. Alhakamy, P. Dhar, C.J. Berkland, Mol. Pharm. 13(2016) 1047-1057.
12. [12]
  M. Silhol, M. Tyagi, M. Giacca, et al., Eur. J. Biochem. 269(2002) 494-501. doi: 10.1046/j.0014-2956.2001.02671.x
13. [13]
  M.A. Zanta, P. Belguise-Valladier, J.P. Behr, Proc. Natl. Acad. Sci. U. S. A. 96(1999) 91-96. doi: 10.1073/pnas.96.1.91
14. [14]
  S. Bolte, F. Cordelieres, J. Microsc. 224(2006) 213-232. doi: 10.1111/jmi.2006.224.issue-3
15. [15]
  Y. Kim, T.N. Grossmann, G.L. Verdine, Nat. Protoc. 6(2011) 761-771. doi: 10.1038/nprot.2011.324
1. [1]
  Weiyu Chen , Zenghui Li , Chenguang Zhao , Lisha Zha , Junfeng Shi , Dan Yuan . Enzyme-modulate conformational changes in amphiphile peptide for selectively cell delivery. Chinese Chemical Letters, 2024, 35(12): 109628-. doi: 10.1016/j.cclet.2024.109628
2. [2]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
3. [3]
  Jianhui Yin , Wenjing Huang , Changyong Guo , Chao Liu , Fei Gao , Honggang Hu . Tryptophan-specific peptide modification through metal-free photoinduced N-H alkylation employing N-aryl glycines. Chinese Chemical Letters, 2024, 35(6): 109244-. doi: 10.1016/j.cclet.2023.109244
4. [4]
  Zhibin Ren , Shan Li , Xiaoying Liu , Guanghao Lv , Lei Chen , Jingli Wang , Xingyi Li , Jiaqing Wang . Penetrating efficiency of supramolecular hydrogel eye drops: Electrostatic interaction surpasses ligand-receptor interaction. Chinese Chemical Letters, 2024, 35(11): 109629-. doi: 10.1016/j.cclet.2024.109629
5. [5]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
6. [6]
  Rui Wang , He Qi , Haijiao Zheng , Qiong Jia . Light/pH dual-responsive magnetic metal-organic frameworks composites for phosphorylated peptide enrichment. Chinese Chemical Letters, 2024, 35(7): 109215-. doi: 10.1016/j.cclet.2023.109215
7. [7]
  Cheng-Yan Wu , Yi-Nan Gao , Zi-Han Zhang , Rui Liu , Quan Tang , Zhong-Lin Lu . Enhancing self-assembly efficiency of macrocyclic compound into nanotubes by introducing double peptide linkages. Chinese Chemical Letters, 2024, 35(11): 109649-. doi: 10.1016/j.cclet.2024.109649
8. [8]
  Chuanfeng Fan , Jian Gao , Yingkai Gao , Xintong Yang , Gaoning Li , Xiaochun Wang , Fei Li , Jin Zhou , Haifeng Yu , Yi Huang , Jin Chen , Yingying Shan , Li Chen . A non-peptide-based chymotrypsin-targeted long-wavelength emission fluorescent probe with large Stokes shift and its application in bioimaging. Chinese Chemical Letters, 2024, 35(10): 109838-. doi: 10.1016/j.cclet.2024.109838
9. [9]
  Jisheng Liu , Junli Chen , Xifeng Zhang , Yin Wu , Xin Qi , Jie Wang , Xiang Gao . Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment. Chinese Chemical Letters, 2024, 35(9): 109779-. doi: 10.1016/j.cclet.2024.109779
10. [10]
  Jie Ma , Jianxiang Wang , Jianhua Yuan , Xiao Liu , Yun Yang , Fei Yu . The regulating strategy of hierarchical structure and acidity in zeolites and application of gas adsorption: A review. Chinese Chemical Letters, 2024, 35(11): 109693-. doi: 10.1016/j.cclet.2024.109693
11. [11]
  Shaoqing Du , Xinyong Liu , Xueping Hu , Peng Zhan . Targeting novel sites represents an effective strategy for combating drug resistance. Chinese Chemical Letters, 2025, 36(1): 110378-. doi: 10.1016/j.cclet.2024.110378
12. [12]
  Mengfan Zhang , Lingyan Liu , Peng Wei , Wei Feng , Tao Yi . A proximity tagging strategy utilizing an activated aldehyde group as the active site. Chinese Chemical Letters, 2025, 36(4): 110127-. doi: 10.1016/j.cclet.2024.110127
13. [13]
  Han Wu , Yumei Wang , Zekai Ren , Hailin Cong , Youqing Shen , Bing Yu . The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy. Chinese Chemical Letters, 2025, 36(4): 109996-. doi: 10.1016/j.cclet.2024.109996
14. [14]
  Dong Cheng , Youyou Feng , Bingxi Feng , Ke Wang , Guoxin Song , Gen Wang , Xiaoli Cheng , Yonghui Deng , Jing Wei . Polyphenol-mediated interfacial deposition strategy for supported manganese oxide catalysts with excellent pollutant degradation performance. Chinese Chemical Letters, 2024, 35(5): 108623-. doi: 10.1016/j.cclet.2023.108623
15. [15]
  Junhua Wang , Xin Lian , Xichuan Cao , Qiao Zhao , Baiyan Li , Xian-He Bu . Dual polarization strategy to enhance CH₄ uptake in covalent organic frameworks for coal-bed methane purification. Chinese Chemical Letters, 2024, 35(8): 109180-. doi: 10.1016/j.cclet.2023.109180
16. [16]
  Yu-Yu Tan , Lin-Heng He , Wei-Min He . Copper-mediated assembly of SO₂F group via radical fluorine-atom transfer strategy. Chinese Chemical Letters, 2024, 35(9): 109986-. doi: 10.1016/j.cclet.2024.109986
17. [17]
  Wenyu Gao , Liming Zhang , Chuang Zhao , Lixiang Liu , Xingran Yang , Jinbo Zhao . Controlled semi-Pinacol rearrangement on a strained ring: Efficient access to multi-substituted cyclopropanes by group migration strategy. Chinese Chemical Letters, 2024, 35(9): 109447-. doi: 10.1016/j.cclet.2023.109447
18. [18]
  Zheng Zhao , Ben Zhong Tang . An efficient strategy enabling solution processable thermally activated delayed fluorescence emitter with high horizontal dipole orientation. Chinese Journal of Structural Chemistry, 2024, 43(6): 100270-100270. doi: 10.1016/j.cjsc.2024.100270
19. [19]
  A-Yang Wang , Sheng-Hua Zhou , Mao-Yin Ran , Xin-Tao Wu , Hua Lin , Qi-Long Zhu . Regulating the key performance parameters for Hg-based IR NLO chalcogenides via bandgap engineering strategy. Chinese Chemical Letters, 2024, 35(10): 109377-. doi: 10.1016/j.cclet.2023.109377
20. [20]
  Liping Zhao , Xixi Guo , Zhimeng Zhang , Xi Lu , Qingxuan Zeng , Tianyun Fan , Xintong Zhang , Fenbei Chen , Mengyi Xu , Min Yuan , Zhenjun Li , Jiandong Jiang , Jing Pang , Xuefu You , Yanxiang Wang , Danqing Song . Novel berberine derivatives as adjuvants in the battle against Acinetobacter baumannii: A promising strategy for combating multi-drug resistance. Chinese Chemical Letters, 2024, 35(10): 109506-. doi: 10.1016/j.cclet.2024.109506

Get Citation

PDF

XML

Metrics

PDF Downloads(9)
Abstract views(1145)
HTML views(43)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142